Janney Montgomery Scott’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
Other funds holding PPH
JSAM
AT
AWC
Janney Montgomery Scott's PPH Position: Q2 2026 in Review
Janney Montgomery Scott reduced its VanEck Pharmaceutical ETF (PPH) stake by 36% in Q2 2026, selling an estimated $109K and leaving 1,892 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #2974.
Janney Montgomery Scott first reported a position in PPH in Q3 2018 and has held it in 16 quarters since. The position peaked at $493K in Q3 2024. 147 funds tracked by Wall St. Rank hold PPH as of Q2 2026.
- Janney Montgomery Scott held 1,892 shares of VanEck Pharmaceutical ETF worth $207K as of Q2 2026.
- Janney Montgomery Scott sold 1,050 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $109K.
- VanEck Pharmaceutical ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2974 holding.
- Janney Montgomery Scott first reported a position in VanEck Pharmaceutical ETF in Q3 2018 and has held it in 16 quarters since.
- Janney Montgomery Scott's VanEck Pharmaceutical ETF position peaked at $493K in Q3 2024.
- 147 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.
Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.